TherapeuticsMD Profit Margin

TherapeuticsMD (TXMD) currently reports a profit margin of 4.91% as of September 2026. That compares with 18.65% in the prior-year period — down 73.7% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore TherapeuticsMD's profit margin history and peer comparisons.

TherapeuticsMD's profit margin decreased from 18.65% to 4.91% — a 73.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TherapeuticsMD's profit margin of 4.91% is lower than the Healthcare sector average of 19.13%. That is roughly 74.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but TherapeuticsMD's current 4.91% should be judged against Healthcare norms (sector average: 19.13%) and against TXMD's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 4.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for TherapeuticsMD, and consider following TXMD for alerts when major investors trade the stock.